United Kingdom· GB-APID-39115411000001101
Atectura Breezhaler 125micrograms/127.5micrograms inhalation powder capsules with device
A medicinal product containing indacaterol + mometasone, registered in United Kingdom by Novartis Pharmaceuticals UK Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Indacaterol + Mometasone
- Manufacturer
- Novartis Pharmaceuticals UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin07613421042257
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indacaterol + mometasone in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaATECTURA BREEZHALERNovartis Europharm Limited, Dublin
- SpainATECTURA BREEZHALER 125 microgramos/127,5 microgramos POLVO PARA INHALACION (CAPSULA DURA)Novartis Europharm Limited
- PolandAtectura BreezhalerNovartis Europharm Limited
- FinlandAtectura BreezhalerNovartis Europharm Limited
- SwitzerlandAtectura Breezhaler
- SwedenAtectura Breezhaler 125 mikrogram/127,5 mikrogram Inhalationspulver, hård kapselNovartis Europharm Limited
- IcelandAtectura BreezhalerNovartis Europharm Limited*
- IrelandAtectura Breezhaler 125 micrograms/127.5 micrograms inhalation powder, hard capsulesNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Atectura Breezhaler, Bemrist Breezhaler
- Liechtenstein · Atectura Breezhaler, Bemrist Breezhaler
- Norway · Atectura Breezhaler, Bemrist Breezhaler
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2c34e62a-bde9-4b6a-846a-015b6f257bad GET /v1/drugs/2c34e62a-bde9-4b6a-846a-015b6f257bad?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39115411000001101",
"desc": "Atectura Breezhaler 125micrograms/127.5micrograms inhalation powder capsules with device (Novartis Pharmaceuticals UK Ltd)",
"form": "Inhalation powder",
"vpid": "39116311000001103",
"source": "dmd",
"vtm_id": "39110211000001109",
"strength": "125 microgram",
"substance": "Indacaterol + Mometasone",
"ingredient": "Indacaterol acetate",
"supplier_code": "2920101000001102"
}See everything about indacaterol + mometasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.